Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even
after normalization of blood pressure in patients with hypertension. Underlying immune cell …

Hypertension is a global health problem, with> 1.3 billion individuals with high blood
pressure worldwide. In this Review, we present an inflammatory paradigm for hypertension …

Emerging evidence has supported a role of inflammation and immunity in the genesis of
hypertension. In humans and experimental models of hypertension, cells of the innate and …

Hypertension is regarded as the most prominent risk factor for cardiovascular diseases,
which have become a primary cause of death, and recent research has demonstrated that …

Hypertension is considered as the most common risk factor for cardiovascular disease.
Inflammatory processes link hypertension and cardiovascular disease, and participate in …

Inflammation plays an important role in the pathogenesis of hypertension. Innate and
adaptive immune response may contribute to this process. The mechanisms implicating …

For more than 50 years, evidence has accumulated that inflammation contributes to the
pathogenesis of hypertension. Immune cells have been observed in vessels and kidneys of …

Increasing evidence indicates that hypertension and hypertensive end-organ damage are
not only mediated by hemodynamic injury. Inflammation also plays an important role in the …

Hypertension is the primary cause of cardiovascular mortality. Despite multiple existing
treatments, only half of those with the disease achieve adequate control. Therefore …

Research studying the role of inflammation in hypertension and cardiovascular disease has
flourished in recent years; however, the exact mechanisms by which the activated immune …